Follicular Lymphoma: Mosunetuzumab and Lenalidomide Study

We are evaluating a new combination treatment for people with untreated follicular lymphoma to see if it works better than standard chemotherapy. This study aims to improve patient outcomes and quality of life.

>2 years Confirmation phase (III)Post-Trial Drug Access No Placebo Standard Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Allopurinol

Allopurinol is a medicine that lowers uric acid to prevent and treat gout and certain kidney stones.

Bendamustine Hydrochloride

Bendamustine Hydrochloride is a chemotherapy medicine used to treat certain blood cancers, such as chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Filgrastim Hexal

Filgrastim Hexal is a medicine that boosts white blood cell production to help reduce infection risk during chemotherapy or after bone marrow transplant.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Allopurinol

Allopurinol is a substance that lowers uric acid levels to prevent gout attacks and related complications.

Bendamustine Hydrochloride

Bendamustine hydrochloride is a chemotherapy substance used to treat certain blood cancers by killing cancer cells.

Cyclophosphamide

Cyclophosphamide is a cancer-fighting and immune-suppressing substance used to treat various cancers and some severe autoimmune conditions.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

[18f] Fdg

[18f] Fdg Βιοκοσμοσ

[18f] Fludeoxyglucose Biont

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Krankenhaus Der Barmherzigen Brueder

Innere Medizin I

Graz, Austria

Universitaetsklinikum Krems

Department for Internal Medicine II

Krems an der Donau, Austria

Steiermaerkische Krankenanstalten Ges.m.b.H.

Department of Internal Medicine, Hematology and Internal Oncology

Leoben, Austria

Sponsor: Lysarc

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.